中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
41期
2930-2933
,共4页
韩丽英%李亚萍%叶明珠%王博蔚%王强%赵淑华%李荷莲
韓麗英%李亞萍%葉明珠%王博蔚%王彊%趙淑華%李荷蓮
한려영%리아평%협명주%왕박위%왕강%조숙화%리하련
干细胞%胎盘%转染%基因
榦細胞%胎盤%轉染%基因
간세포%태반%전염%기인
Stem cell%Placenta%Transfection%Gene
目的 探讨重组逆转录病毒载体介导mdr1基因转染胎盘源性间充质干细胞(P-MSC)以应用于基因治疗的可行性、安全性.方法 Percoll密度梯度离心法自人胎盘组织中分离培养间充质干细胞(MSC),利用重复感染方法将含有mdr1基因的逆转录病毒载体导入P-MSC,经逆转录多聚酶链式反应(RT-PCR)检测mdr1 mRNA表达,荧光细胞分选法(FAGS)检测目的基因表达,同时对mdr1-MSC的干细胞特性进行鉴定及分析.结果 转染细胞中显示mdrl mRNA表达;转染P-MSC表达P-gp的阳性细胞百分率为(27.6±5.1)%,明显高于非转染组的(0.4±0.1)%,两组比较差异有统计学意义(t=14.291,P<0.01);转染MSC在G0/G1期所占比例为95.40%,符合干细胞增殖特点.超微结构揭示其具有典型的低分化干细胞超微结构特点,且在特异诱导条件下具有向成脂、成骨定向分化潜能.结论 由重组逆转录病毒介导mdr1基因体外转染胎盘源性MSC可获得高效的P-gp表达,且转染细胞可依然保持其干细胞特性.
目的 探討重組逆轉錄病毒載體介導mdr1基因轉染胎盤源性間充質榦細胞(P-MSC)以應用于基因治療的可行性、安全性.方法 Percoll密度梯度離心法自人胎盤組織中分離培養間充質榦細胞(MSC),利用重複感染方法將含有mdr1基因的逆轉錄病毒載體導入P-MSC,經逆轉錄多聚酶鏈式反應(RT-PCR)檢測mdr1 mRNA錶達,熒光細胞分選法(FAGS)檢測目的基因錶達,同時對mdr1-MSC的榦細胞特性進行鑒定及分析.結果 轉染細胞中顯示mdrl mRNA錶達;轉染P-MSC錶達P-gp的暘性細胞百分率為(27.6±5.1)%,明顯高于非轉染組的(0.4±0.1)%,兩組比較差異有統計學意義(t=14.291,P<0.01);轉染MSC在G0/G1期所佔比例為95.40%,符閤榦細胞增殖特點.超微結構揭示其具有典型的低分化榦細胞超微結構特點,且在特異誘導條件下具有嚮成脂、成骨定嚮分化潛能.結論 由重組逆轉錄病毒介導mdr1基因體外轉染胎盤源性MSC可穫得高效的P-gp錶達,且轉染細胞可依然保持其榦細胞特性.
목적 탐토중조역전록병독재체개도mdr1기인전염태반원성간충질간세포(P-MSC)이응용우기인치료적가행성、안전성.방법 Percoll밀도제도리심법자인태반조직중분리배양간충질간세포(MSC),이용중복감염방법장함유mdr1기인적역전록병독재체도입P-MSC,경역전록다취매련식반응(RT-PCR)검측mdr1 mRNA표체,형광세포분선법(FAGS)검측목적기인표체,동시대mdr1-MSC적간세포특성진행감정급분석.결과 전염세포중현시mdrl mRNA표체;전염P-MSC표체P-gp적양성세포백분솔위(27.6±5.1)%,명현고우비전염조적(0.4±0.1)%,량조비교차이유통계학의의(t=14.291,P<0.01);전염MSC재G0/G1기소점비례위95.40%,부합간세포증식특점.초미결구게시기구유전형적저분화간세포초미결구특점,차재특이유도조건하구유향성지、성골정향분화잠능.결론 유중조역전록병독개도mdr1기인체외전염태반원성MSC가획득고효적P-gp표체,차전염세포가의연보지기간세포특성.
Objective To explore the feasibility and safety of mdr1 gene transferred into placenta derived mesenchymal stem cells (P-MSCs) by reconstructed retroviral vector.Methods Human P-MSCs were isolated and expanded by Percoll density gradient and then transduced repeatedly by reconstructed retroviral vector containing mdr1 gene.The transfection and expression of mdr1 gene was detected by reverse transcription-polymerase chain reaction (RT-PCR) and fluorescence-activated cell sorting (FAGS).Meanwhile,the biological features of mdr1-MSCs were identified and analyzed.Results The expression of mdr1 mRNA was found in transfected cells.The expression of P-glycoprotein (P-gp) encoded by mdr1 gene was(27.6 ±5.1)% in the transfected P-MSCs cells versus (0.4 ± 0.1)% in the non-transfected P-MSCs cells (t =14.291,P < 0.01).The percent of P-MSCs at quiescent phase (G0/G1 phase) was around 95.40% and it was in accord with the characterization of stem cells.The mdr1-MSCs exhibited typical ultrastructures of low-differentiated stem cells.Moreover,they still retained the potency of adipogenic and osteogenic differentiation in the presence of appropriate conditioned media.Conclusion A stable expression of P-gp may be obtained by reconstructed retroviral-mediated transfection in vitro.And transfected MSCs retain the characteristics of stem cells.